Legend Biotech Corp (LEGN) Form 6-K — Aug 18, 2026
Legend Biotech Corporation filed a Form 6-K on August 18, 2026 containing proxy materials for its Annual General Meeting, to be held September 24, 2026 at its Bridgewater, New Jersey offices, with a record date of August 17, 2026 covering 388,976,826 ordinary shares outstanding. Shareholders will vote on eight proposals, including re-election of four Class III directors (Robin Meng, Corazon D. Sanders, Li Mao, and Peter Salovey) to three-year terms and ratification of Ernst & Young LLP as independent auditor for fiscal year 2026.
Key figures
- Shares Outstanding
- 388976826
- Agm date
- 2026-09-24
- Record date
- 2026-08-17
- Burn rate fy2025
- 1.23%
- Expected burn rate
- 2.0-3.0%
- Plan runway estimate
- 2 to 4 years
- Rsu plan share increase
- 19100000
- Ads closing price nasdaq
- $28.88
- Rsu plan current reserve
- 26000000
- Outstanding share options
- 3102092
- Proposed dilution percent
- 4.9%
- Director annual cash retainer
- $75,000
- Outstanding full value awards
- 12533517
- Total outstanding equity awards
- 15635609
- Rsu shares remaining jun 30 2026
- 5257658
- Rsu plan total reserve if approved
- 45100000
- Weighted avg option exercise price
- $10.32
- Shares underlying ads held by depositary
- 184208310
AI analysis
Red flags4 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.